Dosing and toxicity summary
Cohort | Dose AG014699 (mg/m2) | Dose temozolomide (mg/m2) | No. patients | Total no. cycles given | Dose-limiting toxicities and other grade 3/4 toxicity | |
---|---|---|---|---|---|---|
Part 1 | 1 | 1 | 100 | 3 | 30 | None |
2 | 2 | 100 | 4 | 11 | None | |
3 | 4 | 100 | 4 | 20 | None | |
4 | 8 | 100 | 4 | 5 | None | |
5 | 12 | 100 | 3 | 11 | None | |
Part 2 | 6 | 12 | 135 | 3 | 6 | None |
7 | 12 | 170 | 3 | 10 | None | |
8 | 12 | 200 | 3 | 16 | None | |
9 | 18 | 200 | 6 | 21 | 1/6 + 3 C2 delay after grade 3 neutropenia |